Genus Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$304K Sell
780
-17,061
-96% -$7.21M 0.03% 177
2026
Q1
$8.44M Sell
17,841
-55
-0.3% -$27.7K 0.97% 30
2025
Q4
$8.35M Buy
17,896
+6,741
+60% +$3.13M 0.97% 38
2025
Q3
$4.75M Sell
11,155
-1,525
-12% -$591K 0.55% 63
2025
Q2
$4.86M Sell
12,680
-3,420
-21% -$1.23M 0.62% 55
2025
Q1
$5.56M Buy
+16,100
New +$5.18M 0.81% 44

Other funds holding HCA

Genus Capital Management's HCA Position: Q2 2026 in Review

Genus Capital Management reduced its HCA Healthcare (HCA) stake by 96% in Q2 2026, selling an estimated $7.21M and leaving 780 shares worth $304K. The position accounts for 0.03% of the portfolio, ranked #177.

Genus Capital Management first reported a position in HCA in Q1 2025 and has held it in 6 quarters since. The position peaked at $8.44M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Genus Capital Management held 780 shares of HCA Healthcare worth $304K as of Q2 2026.
  • Genus Capital Management sold 17,061 HCA Healthcare shares in Q2 2026, an estimated $7.21M.
  • HCA Healthcare made up 0.03% of Genus Capital Management's portfolio in Q2 2026, its #177 holding.
  • Genus Capital Management first reported a position in HCA Healthcare in Q1 2025 and has held it in 6 quarters since.
  • Genus Capital Management's HCA Healthcare position peaked at $8.44M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.